http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004323472-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3566110707c4cc96609d2243a9f4af31 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 2003-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84d4c5ba9149336f8eaf4db75d2b227c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4570e3a2d6a18895aa904630ccd02c1b |
| publicationDate | 2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2004323472-A |
| titleOfInvention | Transdermal absorption enhancer and transdermal absorption preparation |
| abstract | The present invention provides a transdermal absorption enhancer excellent in percutaneous absorption promotion effect and having high safety and usability, and a percutaneous absorption preparation containing such a percutaneous absorption enhancer. A transdermal absorption enhancer comprising dimethylsilanol hyaluronate as an active ingredient, and a combination of the drug and various drugs yielded a transdermal absorption-type preparation with high safety and usability. As the drug, saccharides, particularly hyaluronic acid and its salts are preferably used. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017197470-A |
| priorityDate | 2003-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.